Effect of Treatment of Sleep Apnea in Patients With Paroxysmal Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 109 participants.
Also called NCT02727192
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 109 participants
- Registry
-
NCT02727192
-
- Other papers using this trial's data
- Effect of Continuous Positive Airway Pressure on Arrhythmia in Atrial Fibrillation and Sleep Apnea: A Randomized Controlled Trial
- High levels of the adipokines leptin and metrnl in patients with paroxysmal atrial fibrillation and obstructive sleep apnea are not associated with the severity of sleep apnea or the burden of atrial fibrillation
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Norway
- Registry status
- Completed
Technical summary
Registry record NCT02727192. Randomized; no masking; primary purpose treatment. Start 2016-01-21 (actual); primary completion 2019-07-01 (actual). Results posted on 2021-06-22.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Treatment of Sleep Apnea in Patients With Paroxysmal Atrial Fibrillation
- Condition
- Sleep Disordered Breathing
- Condition
- Sleep Apnea
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- PAP (CPAP or ASV)
- Lead sponsor
- Oslo University Hospital
- Collaborator
- Norwegian Health Association
- Collaborator
- Medtronic
- Collaborator
- ResMed
Record details
- Record id
cardio:ct-nct02727192- Content hash
f502aa1183f15931d96f13f71e5b6ae17014236765498d9f788f8998bc7a5be1